Glenmark Pharma signs pact to market Tiotropium Bromide dry powder inhaler in Western Europe

Glenmark Pharma signs pact to market Tiotropium Bromide dry powder inhaler in Western Europe Glenmark Pharmaceuticals EVP Business Head of Europe and Latin America Achin Gupta said, respiratory is a core area of focus for Glenmark and this deal shows our commitment to increase product offerings within this segment.

No comments:

Post a Comment